Enhanced therapeutic index of liposomal doxorubicin Myocet locally delivered by fibrin gels in immunodeficient mice bearing human neuroblastoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Enhanced therapeutic index of liposomal doxorubicin Myocet locally delivered by fibrin gels in immunodeficient mice bearing human neuroblastoma
Authors
Keywords
Fibrin gel, Myocet, Caelyx, In vivo, Toxicity, Anti-tumour activity
Journal
PHARMACOLOGICAL RESEARCH
Volume 163, Issue -, Pages 105294
Publisher
Elsevier BV
Online
2020-11-17
DOI
10.1016/j.phrs.2020.105294
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fibrin Gels Entrapment of a Poly-Cyclodextrin Nanocarrier as a Doxorubicin Delivery System in an Orthotopic Model of Neuroblastoma: Evaluation of In Vitro Activity and In Vivo Toxicity
- (2019) Maurizio Viale et al. PHARMACEUTICAL RESEARCH
- Fibrin gels entrapment of a doxorubicin-containing targeted polycyclodextrin: Evaluation of in vivo antitumor activity in orthotopic models of human neuroblastoma
- (2019) Maurizio Viale et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Characterization of drug release from fibrin gels loaded with different pharmaceutical and experimental doxorubicin formulations
- (2018) Maurizio Viale et al. Pharmacological Reports
- New doxorubicin nanocarriers based on cyclodextrins
- (2017) Maurizio Viale et al. INVESTIGATIONAL NEW DRUGS
- Advances in nano-delivery systems for doxorubicin: an updated insight
- (2017) Ummarah Kanwal et al. JOURNAL OF DRUG TARGETING
- Using solution X-ray scattering to determine the high-resolution structure and morphology of PEGylated liposomal doxorubicin nanodrugs
- (2016) Y. Schilt et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- New insights and evolving role of pegylated liposomal doxorubicin in cancer therapy
- (2016) Alberto A. Gabizon et al. DRUG RESISTANCE UPDATES
- Emerging delivery systems to reduce doxorubicin cardiotoxicity and improve therapeutic index
- (2015) Esther Tahover et al. ANTI-CANCER DRUGS
- Locoregional Therapy of Hepatocellular Carcinoma
- (2015) Ali Habib et al. Clinics in Liver Disease
- Fibrin gels loaded with cisplatin and cisplatin-hyaluronate complexes tested in a subcutaneous human melanoma model
- (2015) Maurizio Viale et al. INVESTIGATIONAL NEW DRUGS
- An overview of doxorubicin formulations in cancer therapy
- (2015) Sangeeta Rivankar Journal of Cancer Research and Therapeutics
- Recent Advances in Protection against Doxorubicin-induced Toxicity
- (2014) Rade Injac et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- Review and Meta-Analysis of Incidence and Clinical Predictors of Anthracycline Cardiotoxicity
- (2013) Marzia Lotrionte et al. AMERICAN JOURNAL OF CARDIOLOGY
- Use of Fibrin Sealants in Cardiovascular Surgery: A Systematic Review
- (2013) John A. Rousou JOURNAL OF CARDIAC SURGERY
- Doxil® — The first FDA-approved nano-drug: Lessons learned
- (2012) Yechezkel (Chezy) Barenholz JOURNAL OF CONTROLLED RELEASE
- Locoregional Therapy
- (2010) Paul E. Van Schil et al. Journal of Thoracic Oncology
- Doxorubicin Cardiomyopathy
- (2009) Kanu Chatterjee et al. CARDIOLOGY
- Doxorubicin: The Good, the Bad and the Ugly Effect
- (2009) Cristina Carvalho et al. CURRENT MEDICINAL CHEMISTRY
- Fibrin Sealant: Past, Present, and Future: A Brief Review
- (2009) William D. Spotnitz WORLD JOURNAL OF SURGERY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started